---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-165205"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2026-04-21T23:59:59+00:00"
generated_at: "2026-05-15T05:03:02.249675+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics regains Nasdaq minimum bid price compliance after 1-for-25 reverse split

## Summary
- Nasdaq notified Plus Therapeutics on April 20, 2026 that bid price closed at or above $1.00 for 10 consecutive days through April 17.
- Reverse stock split (1-for-25) was effective April 2, 2026 and enabled compliance with Listing Rule 5550(a)(2).
- Nasdaq has closed the matter; PSTV common stock remains listed on The Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001193125-26-165205
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2026-04-21T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312526165205/0001193125-26-165205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312526165205/pstv-20260420.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-165205
- JSON: https://secwatch.observer/filing/0001193125-26-165205.json
- Plain text: https://secwatch.observer/filing/0001193125-26-165205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.